Diverse landscape of dermatologic toxicities from small‐molecule inhibitor cancer therapy
Journal of Cutaneous Pathology2021Vol. 49(1), pp. 61–81
Citations Over Time
Riyad N. H. Seervai, Woo Cheal Cho, Emily Y. Chu, Mario L. Marques‐Piubelli, Debora Alejandra Ledesma, Kristen Richards, Meghan Heberton, Kelly C. Nelson, Priyadharsini Nagarajan, Carlos A. Torres‐Cabala, Víctor G. Prieto, Jonathan L. Curry
Abstract
Dermatologic toxicities from Nibs are diverse and may overlap between classes of Nibs. Recognition of the various types of toxicities from Nibs is critical for patient care in the era of "oncodermatology/dermatopathology."
Related Papers
- → Basiswissen Histologie(2013)9 cited
- → The extent of dermatopathology education: A comparison of pathology and dermatology(2005)24 cited
- → Multiple keratoacanthomas, giant keratoacanthoma and keratoacanthoma centrifugum marginatum: development in a single patient and treatment with oral isotretinoin.(1996)32 cited
- Dermatopathology: A Practical Guide to Common Disorders(1995)
- Dermatopathology in India.(2007)